NeoGenomics Inc. Common Stock vs Vivmark Residential Common Shares of Beneficial Interest — how do they compare? NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B), while Vivmark Residential Common Shares of Beneficial Interest trades at $60.9 (market cap $47.05B). The key difference: Vivmark Residential Common Shares of Beneficial Interest is far larger — about 21.7× NeoGenomics Inc. Common Stock's market cap, and Vivmark Residential Common Shares of Beneficial Interest pays a 4.62% dividend while NeoGenomics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Vivmark Residential Common Shares of Beneficial Interest for 6 Days on average.
| NEO | VMRK | |
|---|---|---|
Market Cap | $2.17B | $47.05B |
Volume | 1,615,943 | 5,012,066 |
Sector | Health | Real Estate |
52-Week High | $19.91 | $70.15 |
52-Week Low | $7.19 | $57.98 |
Typical Hold Time | 0 Days | 6 Days |
Enterprise Value | $2.47B | $56.15B |
Dividend Yield | — | 4.62% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →Vivmark Residential is a residential real estate investment trust that owns and operates apartment communities in U.S. markets. Its portfolio includes apartment homes and development projects.
Read more on VMRK →